Assignee
BLUEROCK THERAPEUTICS LP
US·4 granted patents·13 pending applications·2 citations·filing 2020–2025
Top patents by PatentIndex Score
17 records- 0180US11666710B2Delivery devices for therapeutic substancesBLUEROCK THERAPEUTICS LP·Filed 2021·Granted Jun 6, 2023·1 cites·62 claims
- 0277US12394224B2Detecting cells of interest in large image datasets using artificial intelligenceBLUEROCK THERAPEUTICS LP·Filed 2024·Granted Aug 19, 2025·1 cites·13 claims
- 0373US12296154B2Delivery devices for therapeutic substancesBLUEROCK THERAPEUTICS LP·Filed 2023·Granted May 13, 2025·0 cites·45 claims
- 0472US2025269120A1Delivery devices for therapeutic substancesBLUEROCK THERAPEUTICS LP·Filed 2025·Application pending·0 cites
- 0566US2024066060A1Methods for treating inherited metabolic disordersBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 0665US2025161354A1Methods for treating inherited metabolic disordersBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 0764US2022306991A1Methods for obtaining induced pluripotent stem cellsBLUEROCK THERAPEUTICS LP·Filed 2022·Application pending·0 cites
- 0864US2024209322A1Methods for obtaining induced pluripotent stem cellsBLUEROCK THERAPEUTICS LP·Filed 2022·Application pending·0 cites
- 0962US2025290042A1Genetically modified cells for enhanced immune evasion in allogeneic cellular therapiesBLUEROCK THERAPEUTICS LP·Filed 2025·Application pending·0 cites
- 1062US2025333694A1Methods of Making Oligodendrocyte Progenitor CellsBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 1157US2025243462A1Genetically modified cells for enhanced immune evasion in allogeneic cellular therapiesBLUEROCK THERAPEUTICS LP·Filed 2025·Application pending·0 cites
- 1253US2025263695A1Novel sites for safe genomic integration and methods of use thereofBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 1350US2025099331A1Medical device system and method for preparing a doseBLUEROCK THERAPEUTICS LP·Filed 2022·Application pending·0 cites
- 1448US11989960B2Detecting cells of interest in large image datasets using artificial intelligenceBLUEROCK THERAPEUTICS LP·Filed 2020·Granted May 21, 2024·0 cites·8 claims
- 1548US2025352584A1Cell delivery vehicle and methods of using the sameBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 1645US2026097012A1Compositions and methods for treating graft-related arrhythmiaBLUEROCK THERAPEUTICS LP·Filed 2023·Application pending·0 cites
- 1743US2024060047A1Cells with sustained transgene expressionBLUEROCK THERAPEUTICS LP·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →